Study of Single Agent Perifosine for Recurrent Pediatric Solid Tumors

Share this content:

Study of Single Agent Perifosine for Recurrent Pediatric Solid Tumors

Sponsor and Collaborators     
Memorial Sloan-Kettering Cancer Center
University of Wisconsin, Madison
Duke University
Keryx / AOI Pharmaceuticals, Inc.

Contacts

Ira Dunkel, MD     212-639-2153     
Tanya Trippett, MD     212-639-8267     
           
Investigator    
Ira Dunkel, MD     
Memorial Sloan-Kettering Cancer Cente

ClinicalTrials.gov Identifier

NCT00776867

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs